Eli Lilly and Company

Other

Jennifer Marie Tinsley

Gerald Floyd Smith

Valentine Joseph Klimkowski

Michael Robert Wiley

Jason Scott Sawyer

Douglas Wade Beight

Steven E Hall

James Howard Wikel

Robert T Shuman

John Joseph Masters

David Kent Herron

Ying Kwong Yee

David Mendel

Anne Louise Tebbe

Leonard Crayton Weir

Trelia Joyce Craft

Jeffry Bernard Franciskovich

Guy Milot

Jeffrey Alan Kyle

Theodore Goodson, Jr

Sajan Joseph

Marta Maria Pi&ntilde;eiro-N&uacute;&ntilde;ez

Daniel Jon Sall

Ho-Shen Lin

Matthew Joseph Fisher

Minsheng Zhang

Michael Enrico Richett

Jolie Anne Bastian

Richard Waltz Harper

Kumiko Takeuchi

Jefferson Ray McCowan

Robert J Foglesong

Mary George Johnson

Michael Lyle Denney

Nickolay Y Chirgadze

Michael P Lynch

Carl Penman Denny

Alan David Palkowitz

Todd Jonathan Kohn

Marta Maria Pi&ntilde;eiro-Nu&ntilde;ez

Theodore Goodson, Junior

Shawn Christopher Miller

Jeffrey Thomas Mullaney

Marta Maria Pineiro-Nunez

Guy Milet

Theodore Goodson Jr

Jeffrey Bernard Franciskovich

Marta Maria Pinelro-Núnez

This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Aromatic amides

Antithrombotic amides

This application relates to heteroaromatic amides (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Heteroroaromatic amides as inhibitor of factor Xa

This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Antithrombotic agents

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermidates thereof.

The invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts, as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula (I), and the use of the compounds of formula (I) as thrombin inhibitors.

Growing community of inventors

Ypsilanti, MI, United States of America

Jennifer Marie Tinsley